do you mind if I start from the perspective of what percentage of oncologists would not use a form of doxorubicin that works better but also just happens to protect the heart versus doxorubicin alone? If it were me or a loved one undertaking this treatment, I would want some pretty good justification for that choice.
if these trials are successful... wow, wow, wow.
Ann: Breakthrough Zantrene Heart Protection Discovery, page-189
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
-0.030(1.75%) |
Mkt cap ! $286.2M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.73 | $1.68 | $119.9K | 70.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3012 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 6382 | 1 |
View Market Depth
| Last trade - 15.07pm 03/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |